Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride
Abstract Pruritus is known to be a common complication in hepatitis patients, but the exact frequency and degree are not fully elucidated. Thus, we evaluated pruritus of 450 patients with chronic liver disease at our hospital. Pruritus was observed in 240 (53%) of the patients. Pruritus was signific...
Guardado en:
Autores principales: | Shuhei Yoshikawa, Takeharu Asano, Mina Morino, Keita Matsumoto, Hitomi Kashima, Yudai Koito, Takaya Miura, Yuko Takahashi, Rumiko Tsuboi, Takehiro Ishii, Haruka Otake, Junichi Fujiwara, Masanari Sekine, Takeshi Uehara, Kazuhito Yuhashi, Satohiro Matsumoto, Shinichi Asabe, Hiroyuki Miyatani, Hirosato Mashima |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/022457205d40407a922e1172f2dfdefa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction
por: Hiroyuki Miyatani, et al.
Publicado: (2018) -
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Satohiro Matsumoto, et al.
Publicado: (2020) -
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
por: Hurramhon Shokirova, et al.
Publicado: (2021) -
IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity
por: Ayako Takamori, et al.
Publicado: (2018) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018)